Dominic specialises in contentious intellectual property matters, with an emphasis on patent litigation. Reflecting his technical background, he focuses primarily in life sciences disputes, particularly in relation to pharmaceuticals and biotechnology. Dominic has handled cases across the range of tribunals in the UK and the EPO and has coordinated litigation across Europe and the world.
In the pharmaceutical and biotechnology sector, Dominic has worked on all aspects of the drug life cycle, from freedom to operate analyses and early-stage risk assessment of generic competition to complex end-stage litigation, SPCs and anti-trust issues. His extensive experience of cross-border litigation has involved acting for both rights holders and defendants, giving him the broadest possible outlook on strategy and a comprehensive tactical playbook.
Dominic has also handled patent litigation for several household names in the consumer products sector, from triple-blade razors to beer-dispensing apparatus and mechanical cases from bus ramps to printed-circuit board connectors. He also has experience of conducting litigation concerning registered designs and copyright and the issues arising in the publishing, gaming and computer gaming industries.
Dominic writes regularly on reported patent cases in the UK and at the EPO and is a member of CIPA, EPLAW and AIPPI, where he chairs the UK Events Committee and sits on the UK Council. He is a regular conference speaker and presenter.
- MA Natural Sciences, University of Cambridge
- PhD Zoology, University of Cambridge
- Diploma in Intellectual Property Law and Practice, University of Bristol
- Qualified 2004
- Partner 2014
What others say
...the 'exceptionally good' Dominic AdairLegal 500 2019/2018
“Dominic Adair masters the minute details of cases without ever losing sight of the big picture; he advances clients’ strategies beyond the United Kingdom."IAM Patent 1000 2018
"Clients are consistently impressed with Dominic Adair 's "exceptional ability to quickly grasp the key issues of a case", which allows him to "devise optimal international litigation strategies to bring his cases to a successful end".Who's Who Legal 2018
"Dominic Adair recently represented biosimilar manufacturer Celltrion in a revocation action – only the second time that a patent case relating to a biosimilar has been brought to trial in the United Kingdom."IAM Patent 1000 2017
"Cross-border maestro Dominic Adair focuses on pharmaceuticals, with an in-depth understanding of all aspects of the drug’s lifecycle."IAM Patent 1000 2016
"Recently promoted IP litigation expert Dominic Adair assisted Novartis with the international coordination of its patent litigation relating to its drug Galvus; and advised the same client on the defence of its patents for the cancer medicine Glivec."Legal 500 2015
Legal 500 2019/2018
Pharmaceuticals and Biotechnology
Legal 500 2019/2018
Life Sciences, Patent Litigation
Who's Who Legal 2019/2018
IAM Patent 1000 2018
Who's Who Legal Thought Leader 2019/2018
Managing Intellectual Property, IP Stars 2017